Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

HB 406 shortens the review period for medical device regulations from every three years to every two years. It directly affects the Tennessee Board of Pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices. The bill requires an advisory committee - including medical device industry representatives and a department of economic development official - to review these regulations more frequently, focusing on advancements in new medical device technologies. This change updates multiple sections of Tennessee law (Titles 8, 47, 56, 63, and 71) to accelerate the review process. The bill does not alter the content of regulations, only the schedule for their periodic review.